This cluster is routine and non-informative. The sales are small in dollar terms, tied to option exercises, and likely driven by vesting schedules and tax obligations. No bearish read-through is warranted. Monitor for any material news (pipeline updates, partnership announcements) that could move the stock, but this insider activity alone does not signal a change in outlook.
Price Chart
Executive Summary
Three top executives at Monte Rosa Therapeutics (CEO, CSO, COO) sold a combined $260K in open-market sales over a 7-day window, with the CEO's sale occurring most recently. The total dollar value is only ~0.015% of the $1.7B market cap, making this a trivial cluster by proportionality standards. The sales coincide with option exercises, suggesting liquidity-driven diversification rather than a coordinated bearish signal.
Key Financial Metrics
Key Facts
- CEO Markus Warmuth sold 4,998 shares at $19.41 for $97K on June 1, 2026
- CSO Sharon Townson sold 6,000 shares at $19.87 for $119K on May 29, 2026, after exercising options at $6.14/share
- COO Jennifer Champoux sold 2,175 shares at $20.00 for $44K on May 27, 2026, after exercising options at $3.98/share
- Total cluster value of $260K represents ~0.015% of Monte Rosa's $1.7B market cap
- All three sales are accompanied by option exercises (non-cash or cash exercises), consistent with routine vesting and tax planning
Financial Impact
Total insider sales of $260K, or ~0.015% of market cap — immaterial relative to company size
Risk Factors
- CEO's sale on June 1 is the most recent and could be misinterpreted by the market as a negative signal
- Biotech sector volatility could amplify any perceived insider selling, even if immaterial
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GLUE-1780430795741 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 25d ago | 8-K | $11.26 | awaiting T+60 | — | $10.48 (−6.93%) |
Sep 30, 2026 26d ago | Press Release | $11.26 | awaiting T+60 | — | $10.48 (−6.93%) |
Aug 6, 2026 11w ago | 8-K | $15.71 | awaiting T+60 | — | $10.48 (−33.29%) |
Jul 17, 2026 14w ago | Insider Cluster | $23.48 $9.89 | ▼ −57.88% | ▼ −62.72% | $10.48 (−55.37%) |
Jul 7, 2026 15w ago | Insider Cluster | $24.06 $11.93 | ▼ −50.42% | ▼ −52.73% | $10.48 (−56.44%) |
Jul 1, 2026 16w ago | Insider Cluster | $24.21 $11.72 | ▼ −51.59% | ▼ −54.60% | $10.48 (−56.71%) |
Jul 1, 2026 16w ago | Insider Cluster | $24.21 $11.72 | ▼ −51.59% | ▼ −54.60% | $10.48 (−56.71%) |
Jun 29, 2026 17w ago | 144 | $24.20 $11.89 | ▼ −50.87% | ▼ −54.43% | $10.48 (−56.69%) |
Jun 25, 2026 17w ago | Insider Cluster | $22.29 $12.60 | ▼ −43.47% | ▼ −49.56% | $10.48 (−52.98%) |
Jun 2, 2026 20w ago | Insider Cluster | $17.59 $14.32 | ▼ −18.59% | ▼ −21.09% | $10.48 (−40.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers